Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Income Statement [Abstract]
Sales	$ 3,017	$ 183,628	$ 77,044	$ 183,628
Cost of Sales	(2,971)	(172,393)	(75,327)	(172,393)
Gross Profit	46	11,235	1,717	11,235
Operating expenses:
Research and development	393,747	412,341	980,862	987,711
General and administrative	239,628	1,391,278	4,329,306	4,151,380
Total operating expenses	633,375	1,803,619	5,310,168	5,139,091
Loss from operations	(633,329)	(1,792,384)	(5,308,451)	(5,127,856)
Interest expense	(1,082,949)	(1,639,184)	(4,152,437)	(5,141,701)
Net loss	(1,716,278)	(3,431,568)	(9,460,888)	(10,269,557)
Other comprehensive loss:
Foreign currency translation adjustment	556,080	(25,065)	(864,328)	(142,922)
Comprehensive loss	$ (1,160,198)	$ (3,456,633)	$ (10,325,216)	$ (10,412,479)
Net loss per share, basic and diluted	$ (0.07)	$ (0.15)	$ (0.39)	$ (0.44)
Weighted average number of shares outstanding, basic and diluted	24,103,196	23,313,629	24,102,976	23,244,345